Immunoprecise Antibodies Ltd (IPA) Stock Price, Quote & News

Company Profile

ImmunoPrecise Antibodies Ltd. operates as a techbio company. It leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies; and support the discovery and development of therapeutic antibodies. The company's contract research organizations services include B cell Select platforms that enable antibody screening directly from B cells, facilitating the analysis of a set of antibodies, as well as for screening compared to traditional t...

Industry: Biotechnology

Sector: Healthcare

Phone: (800) 620-4187

Website: www.ipatherapeutics.com

Address:

823 Congress Ave, Suite 300, Austin, United States

TruthTooPower Jul. 7 at 2:43 PM

$HOOD $IPA !!! Retro Rockettes Engage!!! Hell Yeah!!!!!!!!!

0 · Reply

look2theblue Jul. 7 at 2:36 PM

$IPA these guys are on track to get acquired. ADC technology here is simply to revolutionary to have a competitor purchase.

0 · Reply

dbr_island Jul. 7 at 2:32 PM

$WOLF just hit $2.25!!!!! $MIRA is the next one I’m telling you $2+ 🎯✅ Here’s why👇 $VIOT $BTOG $IPA let’s get it

0 · Reply

BigRig_Trader Jul. 7 at 2:26 PM

$IPA https://x.com/bigrig_trader/status/1942228373419544651?s=46&t=HgNvzT8oCwyzz9Wr4YO4tA

0 · Reply

kozyman87 Jul. 7 at 2:24 PM

$IPA Strong new Appointment to their bod today. Capital markets experience, CFO at another Biotech company 🧪💪🧨 https://ir.ipatherapeutics.com/news/news-releases/news-details/2025/ImmunoPrecise-Antibodies-Appoints-Industry-Veteran-Jon-Lieber-to-Board-of-Directors/default.aspx

0 · Reply

ZaSponge Jul. 7 at 2:15 PM

$IPA why are these guys so cheap in price ? i see they are the only US company listed on the stock exchange that uses AI in gene and vaccine discovery ?!!!

1 · Reply

teddiskim Jul. 7 at 2:10 PM

$IPA 1.56 was the pullback of the day. get back and close above 1.65

0 · Reply

teddiskim Jul. 7 at 2:03 PM

$IPA is this guy's name really truthtoopower? did he mean truthtopower?

0 · Reply

topstockalerts Jul. 7 at 1:58 PM

Top Gainers PT2 $CURR $WOLF $ENGS $IPA $PRME

0 · Reply

TruthTooPower Jul. 7 at 1:56 PM

$IPA !!! Retro Rockettes Engage!!! Hell Yeah!!!!!!!!!

0 · Reply

ImmunoPrecise Antibodies Appoints Industry Veteran Jon Lieber to Board of Directors

Jul 3, 2025, 8:19 AM EDT - 4 days ago

ImmunoPrecise Validates LENSai Epitope Mapping Platform Across Broad Range of Unseen Therapeutic Targets Beyond Training Data

Jun 24, 2025, 7:02 AM EDT - 13 days ago

ImmunoPrecise Advances Universal Dengue Vaccine, Confirming Safety, Immune Activation, and Structural Stability Using its LENSai™ Platform Powered by Patented HYFT® Technology

Jun 12, 2025, 8:01 AM EDT - 25 days ago

AI-Designed GLP-1 Peptides from ImmunoPrecise Antibodies Surpass Semaglutide in Receptor Activation Studies

Jun 5, 2025, 8:01 AM EDT - 4 weeks ago

ImmunoPrecise Announces AI-Driven Breakthrough in Universal Dengue Vaccine Discovery

AMD

May 21, 2025, 8:49 AM EDT - 6 weeks ago

ImmunoPrecise Antibodies Engages CORE IR to Enhance Investor Engagement Efforts

May 20, 2025, 8:28 AM EDT - 6 weeks ago

ImmunoPrecise Antibodies (IPA) to Present at Maxim Group's 2025 Virtual Tech Conference

May 12, 2025, 8:01 AM EDT - 2 months ago

IPA's LENSai™ Platform Delivers X-Ray–Level Epitope Mapping Insights in Hours, Matching Gold-Standard Methods with Greater Speed

AMD

Apr 11, 2025, 8:40 AM EDT - 3 months ago

ImmunoPrecise Antibodies Highlights Alignment of Proprietary AI-Driven Platform LENSai™ with FDA's Shift to Non-Animal Testing Methods

Mar 28, 2025, 12:59 PM EDT - 3 months ago

ImmunoPrecise Antibodies Ltd. (IPA) Q3 2025 Earnings Call Transcript

Mar 28, 2025, 8:01 AM EDT - 3 months ago

ImmunoPrecise Antibodies (IPA) Reports Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2025

Mar 13, 2025, 7:02 AM EDT - 4 months ago

ImmunoPrecise Antibodies and a Global Biotechnology Leader Enter into a USD $8M-$10M Partnership for the Development of Novel Cancer Therapeutics.

Mar 11, 2025, 10:17 PM EDT - 4 months ago

IPA to Reschedule Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2025 on March 28, 2025

Mar 5, 2025, 8:01 AM EST - 4 months ago

IPA to Report Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2025 on March 13, 2025

Feb 26, 2025, 8:01 AM EST - 4 months ago

IPA and RIBOPRO Partner to Advance mRNA-Driven Antibody Discovery, Unlocking New Frontiers in Immunotherapy

Feb 24, 2025, 8:01 AM EST - 4 months ago

ImmunoPrecise Antibodies Announces Key Leadership Changes

Feb 20, 2025, 8:01 AM EST - 4 months ago

ImmunoPrecise Antibodies Announces Transfer to Nasdaq Capital Market and Extension of Bid Price Compliance Period

Jan 27, 2025, 8:01 AM EST - 5 months ago

ImmunoPrecise Antibodies (IPA) Announces Completion of At-the-Market Equity Offering and Full Conversion of Yorkville Debenture

Jan 22, 2025, 7:02 AM EST - 5 months ago

IPA (ImmunoPrecise Antibodies) Pioneers AI-Designed GLP-1 Therapies: A Potential New Chapter in Diabetes Treatment

Jan 17, 2025, 8:01 AM EST - 6 months ago

ImmunoPrecise Antibodies Realigns Pipeline Strategy, Empowering Drug Discovery with AI and First-Principles Innovation

Dec 31, 2024, 7:56 PM EST - 6 months ago

IPA Announces Resignation of Chief Financial Officer

Dec 30, 2024, 10:03 PM EST - 6 months ago

$116 Million Multifamily Asset Sale in Central California Coast Region Brokered by Marcus & Millichap's Institutional Property Advisors

MMI

Dec 23, 2024, 8:30 AM EST - 7 months ago

ImmunoPrecise Antibodies (IPA) Demonstrates Strong Market Confidence with Insider Share Purchases

Dec 19, 2024, 10:15 AM EST - 7 months ago

IPA to Present at The Microcap Conference 2025

Dec 10, 2024, 5:33 PM EST - 7 months ago

ImmunoPrecise Antibodies Ltd. (IPA) Q2 2025 Earnings Call Transcript

Dec 10, 2024, 8:30 AM EST - 7 months ago

ImmunoPrecise Antibodies (IPA) Reports Financial Results and Recent Business Highlights for Second Quarter Fiscal Year 2025

Dec 4, 2024, 8:00 AM EST - 7 months ago

IPA to Present at The Benchmark Company's Upcoming Discovery One-on-One Investor Conference

Dec 3, 2024, 8:30 AM EST - 7 months ago

IPA to Report Financial Results and Recent Business Highlights for Second Quarter Fiscal Year 2025 on December 10, 2024

Nov 13, 2024, 9:00 AM EST - 8 months ago

$20 Billion Market Breakthrough: IPA Pioneers High-Impact Antibody Development for Next-Generation ADC Cancer Therapies

Nov 4, 2024, 8:01 AM EST - 8 months ago

ImmunoPrecise to Host TECHDAY: Cutting-Edge AI and Biologics Innovation

Oct 28, 2024, 7:30 AM EDT - 9 months ago

ImmunoPrecise Advances Anti-Aging Research with Mayo Clinic Study, Poised to Tap into $81 Billion Market with AI Technology

Oct 21, 2024, 9:00 AM EDT - 9 months ago

ImmunoPrecise Antibodies to Participate at the AI Driven Drug Discovery Summit USA 2024

Oct 16, 2024, 2:54 PM EDT - 9 months ago

Institutional Property Advisors Brokers $92.5 Million Multifamily Sale in L.A.'s NoHo Arts District

MMI

Oct 10, 2024, 8:10 AM EDT - 9 months ago

ImmunoPrecise Antibodies Celebrates Nobel Prize in Chemistry, Advances in AI-Powered Protein Design

Oct 2, 2024, 8:00 AM EDT - 9 months ago

ImmunoPrecise Subsidiary Signs Material Transfer Agreement with Biotheus

Sep 26, 2024, 9:00 AM EDT - 10 months ago

ImmunoPrecise Antibodies Advances Therapeutic Innovation with Groundbreaking Rabbit Antibody Developments

Sep 16, 2024, 1:46 PM EDT - 10 months ago

ImmunoPrecise Antibodies Ltd. (IPA) Q1 2025 Earnings Call Transcript

Sep 16, 2024, 9:00 AM EDT - 10 months ago

ImmunoPrecise Antibodies (IPA) Reports Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2025

Sep 9, 2024, 9:11 AM EDT - 10 months ago

IPA to Report Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2025 on September 16, 2024

Aug 26, 2024, 9:00 AM EDT - 11 months ago

ImmunoPrecise Antibodies to Participate at H.C. Wainwright's 26th Annual Global Investment Conference in New York

Aug 23, 2024, 8:00 PM EDT - 11 months ago

ImmunoPrecise Antibodies Receives Nasdaq Notification Regarding Minimum Bid Requirements

Aug 19, 2024, 9:00 AM EDT - 11 months ago

ImmunoPrecise Antibodies Successfully Engineers in silico Antibodies to Elusive Tumor Protein Using Its Patented LENSai Technology

Jul 29, 2024, 8:36 PM EDT - 1 year ago

ImmunoPrecise Antibodies Ltd. (IPA) Q4 2024 Earnings Call Transcript

Jul 29, 2024, 8:30 AM EDT - 1 year ago

ImmunoPrecise Antibodies (IPA) Reports Financial Results and Business Updates for Fourth Quarter and Full Fiscal Year 2024

Jul 23, 2024, 7:30 PM EDT - 1 year ago

ImmunoPrecise Antibodies to Reschedule Financial Results and Recent Business Highlights Report for Fourth Quarter and Fiscal Year-End 2024

Jul 16, 2024, 8:01 PM EDT - 1 year ago

ImmunoPrecise Announces Financing Agreement with Yorkville Advisors Global, LP of up to $3.0 Million Aggregate Principal Amount of Convertible Debentures

Jul 15, 2024, 8:31 AM EDT - 1 year ago

IPA to Report Financial Results and Recent Business Highlights for Fourth Quarter and Fiscal Year End 2024 on July 25th, 2024

Jun 27, 2024, 8:01 AM EDT - 1 year ago

ImmunoPrecise Appoints Kristin Taylor as Chief Financial Officer

Jun 25, 2024, 7:02 AM EDT - 1 year ago

IPA's Subsidiary BioStrand and PGxAI Announce Strategic Collaboration to Develop First-In-Class AI Model for Pharmacogenomics Recommendations Using LENSai™

Jun 12, 2024, 7:00 AM EDT - 1 year ago

ImmunoPrecise Antibodies Ltd. Subsidiary BioStrand Receives Prestigious 2024 Impact Award for Groundbreaking LENSai™ Technology

TruthTooPower Jul. 7 at 2:43 PM

$HOOD $IPA !!! Retro Rockettes Engage!!! Hell Yeah!!!!!!!!!

0 · Reply

look2theblue Jul. 7 at 2:36 PM

$IPA these guys are on track to get acquired. ADC technology here is simply to revolutionary to have a competitor purchase.

0 · Reply

dbr_island Jul. 7 at 2:32 PM

$WOLF just hit $2.25!!!!! $MIRA is the next one I’m telling you $2+ 🎯✅ Here’s why👇 $VIOT $BTOG $IPA let’s get it

0 · Reply

BigRig_Trader Jul. 7 at 2:26 PM

$IPA https://x.com/bigrig_trader/status/1942228373419544651?s=46&t=HgNvzT8oCwyzz9Wr4YO4tA

0 · Reply

kozyman87 Jul. 7 at 2:24 PM

0 · Reply

ZaSponge Jul. 7 at 2:15 PM

$IPA why are these guys so cheap in price ? i see they are the only US company listed on the stock exchange that uses AI in gene and vaccine discovery ?!!!

1 · Reply

teddiskim Jul. 7 at 2:10 PM

$IPA 1.56 was the pullback of the day. get back and close above 1.65

0 · Reply

teddiskim Jul. 7 at 2:03 PM

$IPA is this guy's name really truthtoopower? did he mean truthtopower?

0 · Reply

topstockalerts Jul. 7 at 1:58 PM

Top Gainers PT2 $CURR $WOLF $ENGS $IPA $PRME

0 · Reply

TruthTooPower Jul. 7 at 1:56 PM

$IPA !!! Retro Rockettes Engage!!! Hell Yeah!!!!!!!!!

0 · Reply

SadyK189 Jul. 7 at 1:53 PM

$IPA My post on weekend "Initially alerted at 0.82. Looking good on daily chart. Key support at 0.95 - 1.05. Next key level to test is 1.6 - 1.75" It hit our desired zone, went till 1.68 today

0 · Reply

dontknowgoat Jul. 7 at 1:48 PM

$IPA if you would have been patient and done this. You be up pretty good 🤭👍🐐

0 · Reply

teddiskim Jul. 7 at 1:46 PM

$IPA look at that volume

0 · Reply

equityzone Jul. 7 at 1:37 PM

$IPA The first one out the gates— Up 20+ % already.

0 · Reply

premarketmaker Jul. 7 at 1:36 PM

$IPA ImmunoPrecise Antibodies

0 · Reply

premarketmaker Jul. 7 at 1:34 PM

$IPA $6.50 recent highs

1 · Reply

Stock_Catcher Jul. 7 at 1:26 PM

$IPA multi mover

0 · Reply

teddiskim Jul. 7 at 1:25 PM

$IPA oh you beautiful effin baby..starting the week off great!

0 · Reply

Stocksforfun25 Jul. 7 at 1:02 PM

$IPA when u keep buying the did and it pays off 😆😎

0 · Reply

dontknowgoat Jul. 7 at 12:17 PM

$IPA love this up beat were seeing. IPA new highs everyday. 👍

0 · Reply

NyseDayTrader Jul. 7 at 12:01 PM

$IPA still only a 60 million cap for the future of discovery! Much more value here

0 · Reply

blackpearl1 Jul. 7 at 10:42 AM

$IPA $VOR is a champ baby! LFG!!!

0 · Reply

Market Cap	59.95M
Revenue (ttm)	18.16M
Net Income (ttm)	-20.13M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-110.85%
Debt to Equity Ratio	0.00

Volume	2,705,100
Avg Vol	2,219,386
Day's Range	N/A - N/A
Shares Out	45.77M
Stochastic %K	100%
Beta	0.44
Analysts	Strong Sell
Price Target	$4.00